Publication
Adverse event-related discontinuation of maintenance Bacillus Calmette-Guérin therapy and oncological outcomes in non-muscle-invasive bladder cancer.
Ryota Nakayasu, Akihiro Hamada, Toru Sakatani, Kei Mizuno, Takayuki Sumiyoshi, Kimihiko Masui, Takayuki Goto, Takashi Kobayashi, Yuki Kita
- Source
- PubMed
- Retrieved
- Sep 13, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260913-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Maintenance Bacillus Calmette-Guérin (BCG) therapy is a key component of treatment for intermediate-risk to high-risk non-muscle-invasive bladder cancer (NMIBC) and an essential backbone for combination immunotherapy. However, its implementation remains limited by concerns regarding…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Bladder Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available